BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 23435874)

  • 1. Toll-like receptors in human papillomavirus infection.
    Zhou Q; Zhu K; Cheng H
    Arch Immunol Ther Exp (Warsz); 2013 Jun; 61(3):203-15. PubMed ID: 23435874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HPV viral regulatory mechanism of TLRs and the related treatments for HPV-associated cancers.
    Qi SY; Yang MM; Li CY; Yu K; Deng SL
    Front Immunol; 2024; 15():1407649. PubMed ID: 38812510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Toll-like receptors in microbiota-associated gastrointestinal cancer metastasis.
    Lu Q; Ding H; Li W
    J Cancer Res Ther; 2013 Nov; 9 Suppl():S142-9. PubMed ID: 24516050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAGE and TLRs: relatives, friends or neighbours?
    Ibrahim ZA; Armour CL; Phipps S; Sukkar MB
    Mol Immunol; 2013 Dec; 56(4):739-44. PubMed ID: 23954397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptors and innate immunity.
    Kumar H; Kawai T; Akira S
    Biochem Biophys Res Commun; 2009 Oct; 388(4):621-5. PubMed ID: 19686699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses.
    Ma Z; Zhang E; Yang D; Lu M
    Cell Mol Immunol; 2015 May; 12(3):273-82. PubMed ID: 25418467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Toll-like receptor transcriptome in squamous cell carcinoma of cervix: A case-control study.
    Aggarwal R; Misra S; Guleria C; Suri V; Mangat N; Sharma M; Nijhawan R; Minz R
    Gynecol Oncol; 2015 Aug; 138(2):358-62. PubMed ID: 26024767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogen recognition receptors: ligands and signaling pathways by Toll-like receptors.
    Sasai M; Yamamoto M
    Int Rev Immunol; 2013 Apr; 32(2):116-33. PubMed ID: 23570313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseases.
    Lin Q; Li M; Fang D; Fang J; Su SB
    Int Immunopharmacol; 2011 Oct; 11(10):1422-32. PubMed ID: 21600309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Innate immunity: structure and function of TLRs].
    Delneste Y; Beauvillain C; Jeannin P
    Med Sci (Paris); 2007 Jan; 23(1):67-73. PubMed ID: 17212934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptors in inflammation of the central nervous system.
    Kong Y; Le Y
    Int Immunopharmacol; 2011 Oct; 11(10):1407-14. PubMed ID: 21600311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitination in host immune response to human papillomavirus infection.
    Zhou Q; Zhu K; Cheng H
    Arch Dermatol Res; 2011 May; 303(4):217-30. PubMed ID: 21400034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How important are Toll-like receptors for antimicrobial responses?
    Carpenter S; O'Neill LA
    Cell Microbiol; 2007 Aug; 9(8):1891-901. PubMed ID: 17521328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immunity: toll-like receptors and some more. A brief history, basic organization and relevance for the human newborn.
    Fleer A; Krediet TG
    Neonatology; 2007; 92(3):145-57. PubMed ID: 17476116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor regulation of effector T lymphocyte function.
    Reynolds JM; Dong C
    Trends Immunol; 2013 Oct; 34(10):511-9. PubMed ID: 23886621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct and indirect role of Toll-like receptors in T cell mediated immunity.
    Xu D; Liu H; Komai-Koma M
    Cell Mol Immunol; 2004 Aug; 1(4):239-46. PubMed ID: 16225766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential use of Toll-like receptor (TLR) agonists and antagonists as prophylactic and/or therapeutic agents.
    Makkouk A; Abdelnoor AM
    Immunopharmacol Immunotoxicol; 2009; 31(3):331-8. PubMed ID: 19555209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptors and genital tract infection.
    Sonnex C
    Int J STD AIDS; 2010 Mar; 21(3):153-7. PubMed ID: 20215617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptors in innate immunity.
    Takeda K; Akira S
    Int Immunol; 2005 Jan; 17(1):1-14. PubMed ID: 15585605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.